Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 307

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

VAD‐based regimens as primary treatment for multiple myeloma

Alexanian, Raymond, Barlogie, Bart, Tucker, Susan·1990·American Journal of Hematology

Abstract

An alternating VCAD‐VAD regimen, combining vincristine‐doxorubicin by continuous infusion with cyclophosphamide and pulse dexamethasone, or VAD alone, was given to 175 previously untreated patients with multiple myeloma. The response rate with primary VAD‐based regimens of 55% was virtually identical to the 54% in comparable patients treated previously with similar programs by using bolus vincristine‐doxorubicin. Despite responses to VAD that were more rapid in onset than any previous treatment, remission and survival times were similar. This may be due to major differences in drug sensitivity between progenitor and differentiated plasma cells. A VAD‐based regimen seems better for newly diagnosed patients when rapid control of multiple myeloma is necessary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.2830330203

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 307

Metadata

Authors
Alexanian, R., Barlogie, B., & Tucker, S.
Venue
American Journal of Hematology
Publisher
Wiley
Published
1990-02
Volume
33
Issue
2
Pages
86-89
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W1992935261
Cited by
307
References
12
FWCI
4.71
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: VAD‐based regimens as primary treatment for multiple myeloma. https://app.cochat.ai/papers/10.1002/ajh.2830330203
The paper
Alexanian, R., Barlogie, B., & Tucker, S. (1990). VAD‐based regimens as primary treatment for multiple myeloma. American Journal of Hematology. https://doi.org/10.1002/ajh.2830330203

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.